TRINOMAB
Trinomab Biotech is a clinical-stage biopharmaceutical company specializing in the discovery and development of novel fully native human monoclonal antibody (mAb) drugs. The company's core technology is known as HitmAb, a proprietary technology platform with differentiated advantages and high efficiency for the discovery of fully native human mAbs against infectious diseases, autoimmune disorders, malignant tumors, and other human diseases.
TRINOMAB
Social Links:
Industry:
Health Care
Founded:
2015-01-01
Address:
Zhuhai, Guangdong, China
Country:
China
Website Url:
http://www.trinomab.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.05 B CNY
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Mobile Non Scaleable Content HSTS Nginx Microsoft Azure DNS DigiCert SSL RapidSSL Alibaba
Similar Organizations
Caregiver
Caregiver is a behavioral health company,
Doctor Anywhere
Doctor Anywhere is a telehealth company .
FiNC
FiNC combines data analysis, rich content, and social elements to help users log, understand, manage, and improve their health and wellness.
Fresenius Medical Care North America
Fresenius Medical Care North America provides healthcare services to people with renal and other chronic conditions.
Kenbi
Kenbi is a nurse centric outpatient care company.
La Renon
La Renon is a global healthcare company.
Better Health Group
Better Health Group is a healthcare company.
Thrive Health Tech
Thrive Health Tech is a healthcare-focused mobile company.
Sanara MedTech
Sanara MedTech develop, market, and distribute biotechnology products to physicians, hospitals, clinics and all post-acute care settings.
Current Employees Featured
Founder
Investors List
Guolian Capital
Guolian Capital investment in Venture Round - Trinomab
Jiaxing Weilong Equity Investment
Jiaxing Weilong Equity Investment investment in Venture Round - Trinomab
Shenhong Gejin
Shenhong Gejin investment in Venture Round - Trinomab
Kingray Capital
Kingray Capital investment in Venture Round - Trinomab
Haichuang Anda
Haichuang Anda investment in Venture Round - Trinomab
Xintaige
Xintaige investment in Venture Round - Trinomab
China Medical System Holdings Limited
China Medical System Holdings Limited investment in Venture Round - Trinomab
Yifeng Capital
Yifeng Capital investment in Venture Round - Trinomab
Zhuhai Gree Financial Investment Management
Zhuhai Gree Financial Investment Management investment in Venture Round - Trinomab
Qinwan Capital
Qinwan Capital investment in Venture Round - Trinomab
Official Site Inspections
http://www.trinomab.com Semrush global rank: 5.73 M Semrush visits lastest month: 1.24 K
- Host name: 47.106.64.40
- IP address: 47.106.64.40
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Trinomab"
Zhuhai Trinomab Pharmaceutical Co., Ltd.
Jun 11, 2025 Zhuhai Trinomab Biopharmaceutical Co., Ltd. (referred to as "Trinomab") , founded in 2015, is an innovation-driven biopharmaceutical company committed to developing blood …See details»
trinomab.com - 珠海泰诺麦博制药股份有限公司
Jun 11, 2025 做有临床价值的天然全人源抗体药物 关于泰诺麦博 珠海泰诺麦博制药股份有限公司（简称“泰诺麦博”及“Trinomab”）成立于2015年，是一家面向 …See details»
Trinomab - Crunchbase Company Profile & Funding
Trinomab Biotech is a clinical-stage biopharmaceutical company specializing in …See details»
Trinomab Biotech Co., Ltd - Drug pipelines, Patents, …
Jul 10, 2025 Explore Trinomab Biotech Co., Ltd with its drug pipeline, therapeutic area, technology platform, 15 clinical trials, 1 news, and 2 …See details»
Trinomab leverages HitmAb® to set foot in the field of rabies …
On September 28, 2021, the World Rabies Day, Trinomab announced that it will take full advantage of its core technology HitmAb® to develop a bivalent fully human anti-rabies …See details»
About Us - About Us - Zhuhai Trinomab Pharmaceutical Co., Ltd.
Zhuhai Trinomab Pharmaceutical Co., Ltd. is an innovative biopharmaceutical company with a global expansion perspective that integrates research and development, production and sales. …See details»
Trinomab - Growth Outlook - Crunchbase
Trinomab is a Healthcare company.Growth Score - The measure of growth based on company activity, operational metrics, and investments Growth Trend - The change in the growth score …See details»
Trinomab - Tech Details - Crunchbase
Trinomab is actively using 16 technologies for its website, according to BuiltWith. These include SPF, HSTS, and Mobile Non Scaleable Content.Trinomab has 1 registered patent in the ' …See details»
Structural basis of human cytomegalovirus neutralization by gB …
May 27, 2025 Affiliations 1 Trinomab Pharmaceutical Co., Ltd., Zhuhai 519040, China. Electronic address: [email protected]. 2 Institute of Neuroscience, State Key Laboratory of …See details»
Trinomab - News & Analysis - Crunchbase
Trinomab is a Healthcare company.Tuesday, November 29, 2022 DealStreetAsia Nov 29, 2022 Chinese biotech firm Trinomab closes $104m pre-IPO round to advance product pipeline Load …See details»
Trinomab has successfully obtained two International System ...
Sep 20, 2024 Trinomab has successfully obtained ISO45001 certificate that demonstrates that the company has established a comprehensive system for risk identification, assessment and …See details»
Product Introduction - Product Development - Zhuhai Trinomab ...
TNM009 Injection is a fully human monoclonal antibody targeting nerve growth factor (NGF) independently developed by the company for pain management. In March 2023, the CDE …See details»
First IPO Application Accepted under the Reinstated Fifth Set of …
2 days ago Translated from Securities Times, Zhang Shuxian July 31 - People's Financial News. On July 31, the Shanghai Stock Exchange (SSE) accepted the STAR Market IPO application …See details»
Pipeline Overview - Product Development - Zhuhai Trinomab ...
Trinomab is building a robust pipeline using state-of-the-art fully native human monoclonal antibody science. The company is focused on developing innovative treatments that will …See details»
Trinomab - Products, Competitors, Financials, Employees, …
Sep 27, 2018 Trinomab is a biopharmaceutical company engaged in the research, development, and commercialization of biopharmaceuticals. Use the CB Insights Platform to explore …See details»
Trinomab Biotech Co., Ltd | Reagan-Udall Foundation
Trinomab is dedicated to discovering and developing novel native human monoclonal antibody (mAb) drug. Trinomab’s lead product, TNM002 injection, is the first recombinant native human …See details»
Trinomab - Contacts, Employees, Board Members, Advisors
Trinomab is a Healthcare company.Trinomab has 2 current employee profiles, including Co-founder, Chairman & CTO Huaxin Liao.See details»
Trinomab - Crunchbase
Trinomab, Curon Biopharma, KSEP, and Shengmei Biotech focus on biopharmaceuticals and healthcare products. Oranger specializes in healthcare services, while Doctor Anywhere is a …See details»
TRINOMAB - BIO International Convention 2025
With its first-in-class, a breakthrough next generation product Sintetol i.e. anti-tetanus antibody approval & launch in 2025, Trinomab has grown into a biopharmaceutical company that is …See details»
Trinomab Biotech Co., Ltd | Expanded Access Navigator
Trinomab is dedicated to discovering and developing novel native human monoclonal antibody (mAb) drug. Trinomab’s lead product, TNM002 injection, is the first recombinant native human …See details»